Coastline Trust CO Alnylam Pharmaceuticals, Inc. Transaction History

Coastline Trust CO

  • $847 Million
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 03, 2022
BUY
$138.54 - $232.0 $166,248 - $278,400
1,200 New
1,200 $240,000
Q1 2022

May 04, 2022
SELL
$127.18 - $173.91 $152,616 - $208,692
-1,200 Closed
0 $0
Q2 2021

Aug 10, 2021
BUY
$128.63 - $176.89 $154,356 - $212,267
1,200 New
1,200 $203,000

Others Institutions Holding ALNY

# of Institutions
642
Shares Held
109M
Call Options Held
1.28M
Put Options Held
1.21M
View Full List

About ALNYLAM PHARMACEUTICALS, INC.

ALNY Quotes by TradingView
  • Ticker ALNY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 123,028,000
  • Market Cap $30.1B
  • Description
  • Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system...
More about ALNY
Track This Portfolio

Track Coastline Trust CO Portfolio

Follow Coastline Trust CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Coastline Trust CO, based on Form 13F filings with the SEC.

News

Stay updated on Coastline Trust CO with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email